| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9312021 | Urology | 2005 | 6 Pages |
Abstract
Prostate brachytherapy results in a high probability of 8-year biochemical progression-free survival for low, intermediate, and high-risk patients. When integrated across risk groups and hormonal status, BMI had no statistically significant influence on biochemical progression-free survival.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Gregory S. Merrick, Wayne M. Butler, Kent E. Wallner, Robert W. Galbreath, Zachariah Allen, Jonathan H. Lief, Edward Adamovich,